Skip to main content

CNS Pharmaceuticals, Inc.

CNSP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001729427

In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.

Members of Congress who traded CNSP

No member of Congress has reported a trade in CNS Pharmaceuticals, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.